Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$286K Sell
10,378
-3,798
-27% -$83.9K ﹤0.01% 3254
2026
Q1
$207K Buy
+14,176
New +$208K ﹤0.01% 3452
2024
Q3
Sell
-13,826
Closed -$364K 3944
2024
Q2
$364K Buy
+13,826
New +$288K ﹤0.01% 2564

Other funds holding RXO

HighTower Advisors's RXO Position: Q2 2026 in Review

HighTower Advisors reduced its RXO (RXO) stake by 27% in Q2 2026, selling an estimated $83.9K and leaving 10,378 shares worth $286K. The position accounts for ﹤0.01% of the portfolio, ranked #3254.

HighTower Advisors first reported a position in RXO in Q2 2024 and has held it in 3 quarters since. The position peaked at $364K in Q2 2024. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • HighTower Advisors held 10,378 shares of RXO worth $286K as of Q2 2026.
  • HighTower Advisors sold 3,798 RXO shares in Q2 2026, an estimated $83.9K.
  • RXO made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3254 holding.
  • HighTower Advisors first reported a position in RXO in Q2 2024 and has held it in 3 quarters since.
  • HighTower Advisors's RXO position peaked at $364K in Q2 2024.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.